| 000 | 02583 a2200637 4500 | ||
|---|---|---|---|
| 005 | 20250515073446.0 | ||
| 264 | 0 | _c20070830 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/CIRCULATIONAHA.107.689471 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXuan, Yu-Ting | |
| 245 | 0 | 0 |
_aEndothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway. _h[electronic resource] |
| 260 |
_bCirculation _cJul 2007 |
||
| 300 |
_a535-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAdaptation, Physiological _xphysiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xbiosynthesis |
| 650 | 0 | 4 |
_aDNA _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinase 1 _xphysiology |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinase 2 _xphysiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMice, Mutant Strains |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xphysiology |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xphysiology |
| 650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xphysiopathology |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xdeficiency |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type III |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase C-epsilon _xphysiology |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aSTAT1 Transcription Factor _xphysiology |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xphysiology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 |
_aStress, Physiological _xphysiopathology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriazenes _xpharmacology |
| 700 | 1 | _aGuo, Yiru | |
| 700 | 1 | _aZhu, Yanqing | |
| 700 | 1 | _aWang, Ou-Li | |
| 700 | 1 | _aRokosh, Gregg | |
| 700 | 1 | _aBolli, Roberto | |
| 773 | 0 |
_tCirculation _gvol. 116 _gno. 5 _gp. 535-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.107.689471 _zAvailable from publisher's website |
| 999 |
_c17143064 _d17143064 |
||